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Abstract
Background: Most of what is known about the Helicobacter pylori (H. pylori) cytotoxin, CagA, pertains to a much-vaunted
role as a determinant of gastric inflammation and cancer. Little attention has been devoted to potential roles of CagA in the
majority of H. pylori infected individuals not showing oncogenic progression, particularly in relation to host tolerance.
Regenerating islet-derived (REG)3c encodes a secreted C-type lectin that exerts direct bactericidal activity against Gram-
positive bacteria in the intestine. Here, we extend this paradigm of lectin-mediated innate immunity, showing that REG3c
expression is triggered by CagA in the H. pylori-infected stomach.
Methodology/Principal Findings: In human gastric mucosal tissues, REG3c expression was significantly increased in CagA-
positive, compared to CagA-negative H. pylori infected individuals. Using transfected CagA-inducible gastric MKN28 cells,
we recapitulated REG3c induction in vitro, also showing that tyrosine phosphorylated, not unphosphorylated CagA triggers
REG3c transcription. In concert with induced REG3c, pro-inflammatory signalling downstream of the gp130 cytokine co-
receptor via the signal transducer and activator of transcription (STAT)3 and transcription of two cognate ligands,
interleukin(IL)-11 and IL-6, were significantly increased. Exogenous IL-11, but not IL-6, directly stimulated STAT3 activation
and REG3c transcription. STAT3 siRNA knockdown or IL-11 receptor blockade respectively abrogated or subdued CagA-
dependent REG3c mRNA induction, thus demonstrating a requirement for uncompromised signalling via the IL-11/STAT3
pathway. Inhibition of the gp130-related SHP2-(Ras)-ERK pathway did not affect CagA-dependent REG3c induction, but
strengthened STAT3 activation as well as augmenting transcription of mucosal innate immune regulators, IL-6, IL-8 and
interferon-response factor (IRF)1.
Conclusions/Significance: Our results support a model of CagA-directed REG3c expression in gastric epithelial cells via
activation of the IL-11/gp130/STAT3 pathway. This response might allow Gram-negative H. pylori to manipulate host
immunity to favour its own survival, by reducing the fitness of co-habiting Gram-positive bacteria with which it competes
for resources in the gastric mucosal niche.
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Introduction
Infection with the Gram-negative bacterium Helicobacter pylori
(H. pylori) is the leading cause of gastric cancer worldwide.
Epidemiological studies reveal that strains of H. pylori carrying the
major protein virulence factor, cytotoxin-associated antigen A
(CagA), are associated with an increased risk of gastric cancer
compared to strains of H. pylori lacking CagA [1]. Current
literature indicates that CagA molecules are directly translocated
into gastric epithelial cells via a bacterial type-IV secretion system
(T4SS), analogous to a ‘molecular syringe’ [2]. Translocated CagA
tethers to the inner surface of the plasma membrane [3] and is
tyrosine phosphorylated at specific C-terminal Glu-Pro-Ile-Tyr-
Ala (EPIYA) repeat motifs [4,5].
CagA has been shown to interact with several intracellular
components of signal transduction pathways, predominantly,
though not exclusively, in the tyrosine phosphorylated mode
[4,6,7,8,9,10]. Src-homology protein tyrosine phosphatase (SHP)2
is an intracellular target and pivotal mediator of CagA. SHP2 is
specifically bound by tyrosine phosphorylated CagA and provokes
Ras-dependent and independent signalling via the SHP2-(Ras)-
ERK (MAP-kinase) cascade. CagA-mediated SHP2 signal trans-
duction leads to deregulation of epithelial cell polarity, character-
istically manifested by cell elongation and increased motility, the
‘hummingbird phenotype’ [10]. This cellular response has been
attributed to the acquisition of transformed or invasive phenotype,
drawing parallels in particular with the pro-oncogenic properties
of the epithelial to mesenchymal transition (EMT) [11]. Further
evidence arguing in favour of CagA as a pro-oncogenic factor
comes from mouse transgenic experiments in which CagA
overexpression led to uniform hypertrophy and low frequency,
late onset focal tumourigenesis of the gastric epithelium, notably
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e30786without significant induction of gastritis or atrophy [12]. Thus,
CagA clearly deregulates gastric epithelial homeostasis in a cell
autonomous manner, however the recruitment of secondary
somatic mutations, or additional pro-inflammatory factors is likely
required for complete penetrance of oncogenic potential. Addi-
tionally, CagA has been shown to increase oncogenic transforma-
tion of simian virus (SV)40 large T-antigen and human telomerase
reverse transcriptase (hTERT) pre-immortalized gastric epithelial
cells by Ras-independent activation of ERK1/2 kinase signalling
[13]. While these studies are generally supportive of CagA as a
bacterial oncoprotein with activity in mammalian cells, its
transforming capability is limited and likely allows cancer
progression only in the subset of H. pylori infected individuals
with pre-existing genetic susceptibility.
IL-6 family cytokine signalling via the glycoprotein (gp)130 co-
receptor plays pivotal roles in gastric epithelial homeostasis,
inflammation and cancer [14,15,16,17,18,19]. In the stomach,
signal transduction via gp130 is mediated through two major
arms, the aforementioned SHP2-(Ras)-ERK pathway and the
Janus kinase (JAK)/signal transducer and activator of transcription
(STAT)3 pathway [20]. Augmented gp130/JAK/STAT3 activa-
tion has been reported in CagA-positive H. pylori dependent
gastritis [21], thus arguing for STAT3 hyperactivation driven by
CagA. It is well established that constitutive STAT3 activation is
both pro-inflammatory and oncogenic [20,22], and together these
studies argue in favour of STAT3 as a factor in CagA-related
perturbation of gastric epithelial homeostasis and immunity.
Despite accumulating evidence in support of STAT3 as an
intracellular mediator of CagA function [20,21,23,24], a unifying
molecular mechanism remains elusive. Interleukin (IL)-11 is a
major ligand activator of gastric gp130 signalling and is therefore a
logical candidate for CagA-dependent STAT3 activation. Accord-
ingly, Murata-Kamiya et al. reported increased IL-11 mRNA on
expression microarrays following forced CagA expression in
gastric MKN28 cells, though STAT3 activation was not assessed
[25]. By contrast, a study based in the laryngeal carcinoma-
derived HEp-2 cell line [26] observed IL-6/IL-11 ligand-
independent, but IL-6 receptor alpha (IL6Ra) dependent STAT3
signalling by CagA, irrespective of EPIYA tyrosine phosphoryla-
tion status [23]. On the other hand, studies by us and others
indicate that STAT3 is not activated via IL-6Ra and is triggered
principally by IL-11 in the distal stomach, the preferred niche of
H. pylori [14,15,16,21]. Clarification of the mechanistic and
appropriate tissue-specific contexts of CagA-dependent STAT3
signalling, with particular emphasis upon downstream effector
genes, would undoubtedly illuminate the biological significance of
this host response.
The Regenerating islet-derived (REG)3 genes encode an evolution-
arily conserved family of secreted, C-type lectins with each
member comprised of an approximately 16 kDa carbohydrate
recognition domain (CRD) and N-terminal secretion signal. The
C-type lectin, REG3c has been shown to have broad bactericidal
activity against commensal Gram-positive bacteria in the intestine
by virtue of high affinity binding, via the CRD, to exposed
peptidoglycan carbohydrate residues [27,28,29]. Consistent with
this mode of action, REG3c has no demonstrable activity against
Gram-negative bacteria in which the peptidoglycan layer is
concealed beneath the outer cell membrane [27]. In the intestinal
mucosa REG3c expression is directly induced by bacterial contact
with host surface epithelial cells [27,30]. Collectively, these studies
identify REG3c as an inducible and directly antibacterial C-type
lectin that functions to restrict potentially harmful mucosal
invasion by otherwise beneficial intestinal microflora. In this
capacity REG3c helps to maintain symbiotic host-microbe
relationships thus preserving correct intestinal function and
homeostasis.
Here, using a cohort of human gastric mucosal tissues and
CagA-inducible gastric epithelial cell lines, we show that REG3c is
a transcriptional target of the CagA cytotoxin. Induction of REG3c
is unrelated to CagA-dependent deregulation of cell polarity (via
inappropriate SHP2/ERK activation) and is instead mediated
predominantly by signal transduction by IL-11 via the gp130/
JAK/STAT3 pathway. Though not directly required for REG3c
transcription, we show that reciprocal CagA-dependent SHP2-
(Ras)-ERK signalling subdues pro-inflammatory STAT3 activa-
tion, as well as inhibiting downstream regulators of gastric mucosal
innate immunity. Though others have reported transcriptional
regulation of REG3c by symbiotic and pathogenic bacteria
[27,30,31], our study is the first to describe the regulation of a
C-type-lectin by an isolated bacterial cytotoxin. The broad
significance and applicability of our findings in relation to H.
pylori biology are discussed.
Results
Elevated REG3c expression in CagA-positive H. pylori
infection
We previously showed in the mouse distal stomach that STAT3
activation is required for the induction of C-type lectins, Reg3b
and Reg3c [15]. In a related study, we also reported STAT3
hyperactivation in CagA-positive, compared to CagA-negative H.
pylori-infected epithelial tissue from the human distal stomach [21].
Because of the known bactericidal effects of C-type lectins we were
intrigued by the potential for regulatory effects of pro-inflamma-
tory STAT3 on REG3c in the context of CagA-positive H. pylori
infection. Therefore we determined REG3c expression levels in
gastric epithelial biopsies collected from patients (n=24) showing
histopathologic evidence of gastritis with predetermined H. pylori
infection and CagA cytotoxin status [21]. Quantitative RT-PCR
showed that REG3c expression was dramatically increased in
CagA-positive H. pylori infected gastric mucosal biopsies (mRNA
fold-change 110.4623.3; P,0.01), but strikingly, was not
differentially expressed in CagA-negative H. pylori-infected gastric
mucosal biopsies (mRNA fold-change 14.869.88; P=0.27)
compared to disease-free controls. In further support of a CagA
dependent effect, expression of the canonical CagA responsive
gene, interleukin (IL)-8 [32,33], was increased in a manner
consistent with the changes seen for REG3c (Figure 1). These
results indicate that the bactericidal C-type lectin, REG3c,i s
overexpressed in CagA-positive, but not CagA-negative H. pylori
infection in humans.
Tyrosine phosphorylated CagA triggers REG3c mRNA
expression and activates STAT3 signalling
Having identified REG3c as a likely transcriptional target of
CagA in the gastric epithelium we set out to establish an in vitro
system as an approach to empirically verify this in vivo observation,
as well as providing a means to functionally dissect transcriptional
mechanisms underlying the REG3c response. With these aims in
mind, we employed Tet-OFF MKN28 human gastric epithelial
cell lines with stably integrated, doxycycline (DOX)-repressible
transgenes, carrying sequences that encode either a wild-type
(WT)-CagA protein, a tyrosine phosphorylation resistant mutant
(PR)-CagA protein in which serine residues are substituted for
tyrosine (Y) in the c-terminal EPIYA motifs [4,25]. As demon-
strated here in WT-CagA transfected MKN28 cells, CagA protein
expression is repressed when the cells are exposed to DOX and is
induced by the elimination of DOX from the culture medium
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verify that the expressed CagA protein is active in our MKN28
stable expression system. Accordingly we examined the capacity of
WT (tyrosine-phosphorylated)-CagA induced cells (Figure 2A)t o
reproduce the previously reported cell polarity defect, known as
the ‘hummingbird phenotype’ [4,34]. Induction of this character-
istic loss of cell polarity (indicated by pronounced cell elongation)
was clearly acquired in WT-CagA expressing cells but not in
matched non-induced control cells. In addition, and consistent
with the previously reported dependence of the cell polarity defect
upon CagA tyrosine phosphorylation [4,35], we observed no
morphological changes in PR-CagA inducible cells, despite high
level accumulation of the mutant PR-CagA protein after removal
of DOX (Figure 2A–B). These results confirm the integrity of
tyrosine phosphorylated CagA protein in our inducible expression
system.
To formally substantiate REG3c as a transcriptional target of
CagA, we determined REG3c mRNA levels in our CagA-inducible
cells. Consistent with our observations in vivo, we observed
significantly increased REG3c mRNA abundance in WT-CagA
overexpressing cells compared to non-induced control cells. By
contrast, REG3c mRNA levels were unchanged in PR-CagA
overexpressing cells (Figure 2C) revealing that the REG3c
response is mediated specifically by tyrosine phosphorylated, but
not unphosphorylated CagA.
We sought the identity of candidate signal transduction
pathways that might mediate CagA-dependent REG3c induction.
In previous work we have shown that CagA triggers the gp130/
JAK/STAT3 pathway in human gastric mucosal tissues [21]. We
have also shown that gp130/JAK/STAT3 activation is required
for induction of Reg3b/Reg3c genes in the mouse distal stomach
[15]. Consistent with this expectation we observed increased
abundance of phosphorylated STAT3 (P-STAT3) in WT-CagA
expressing cells however there was no measureable change in P-
STAT3 in PR-CagA expressing cells (Figure 2D). These results
suggested that STAT3 activation is dependent on CagA tyrosine
phosphorylation. To consolidate our findings, we next carried out
transient transfection of WT-CagA or PR-CagA expression
constructs into unmodified (non-stably transfected) AGS and
MKN28 gastric epithelial cell lines. In agreement with our data
from CagA-inducible cells, we observed that only WT-CagA
transfection elicited P-STAT3 accumulation, whereas PR-CagA
transfection had either no effect at all, or quantitatively smaller
effects than WT-CagA on P-STAT3 levels (Figure S2).
Collectively, our data argue that intracellular signalling by tyrosine
phosphorylated CagA, not unphosphorylated CagA, is the
predominant mode of STAT3 activation and REG3c induction
in gastric epithelial cells.
In gastric epithelial cells IL-11, not IL-6 triggers STAT3
signalling and REG3c induction
The cytokines, IL-11 and IL-6 are major ligand activators of
gastric gp130 signalling, via respective interactions with their
specific receptor-alpha chains and subsequent heterotrimeric
complex formation in combination with gp130 homodimers
[20]. Consistent with enhanced STAT3 activation, we found that
overexpression of WT-CagA, but not PR-CagA led to increased
IL-11 and IL-6 transcription (Figure 3A) thus raising the question
of whether either, or both of these cytokines might co-ordinate
CagA-dependent STAT3 activation and REG3c expression. To
clarify this issue we next investigated whether treatment of normal
(non-stably transfected) MKN28 cells with exogenous recombinant
human (rh)IL-11 or IL-6 peptide is sufficient for activation of
STAT3 and induction of REG3c in the absence of CagA.
Treatment of MKN28 cells with rhIL-11 (100 ng/mL) resulted in
rapid P-STAT3 accumulation while, significantly, treatment with
rhIL-6 (100 ng/mL) had no effect on P-STAT3 levels. In addition,
and consistent with our previously reported in vivo analysis of the
mouse distal stomach [15], we found no measurable effect of rhIL-
11 treatment on ERK activation levels, despite rhIL-11 having a
profound stimulatory effect upon parallel STAT3 activation
(Figure 3B). These results indicate that IL-11, not IL-6, is the
cytokine ligand which mediates gastric gp130 signalling by
preferential activation of STAT3. Having clarified this issue, we
investigated the impact of exogenous rhIL-11 stimulation on
REG3c expression levels in MKN28 cells. We found that rhIL-11
ligand-dependent STAT3 activation (Figure 3C) was consistently
associated with dramatic upregulation of REG3c transcription
(Figure 3D) whilst treatment with IL-6 had no effect on either
STAT3 activation (Figure 3B) or REG3c transcription
(Figure 3D). Our data therefore supports a model in which IL-
11, but not IL-6, acts as a key regulator of REG3c expression in
the stomach, very likely via activation of the JAK/STAT3
pathway.
Figure 1. Increased REG3c expression in CagA-positive H. pylori infection. Quantitative (Q) RT-PCR analysis of REG3c and IL8 mRNA levels in
human gastric epithelial biopsies encompassing (i) normal (disease-free) controls; gastritis with (ii) CagA-positive H. pylori-infection; (iii) CagA-
negative H. pylori-infection. Scatter plots show the mean mRNA fold-change relative to normal controls (normalized to the internal reference gene
GAPDH). Black horizontal bars show the mean mRNA fold-change/group. Where present, asterisks show statistical significance (P,0.05).
doi:10.1371/journal.pone.0030786.g001
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requires STAT3 and IL-11
To formally substantiate the role of STAT3 in mediating CagA-
dependent REG3c transcription, a STAT3 specific siRNA was
employed in protein knockdown studies. In pilot experiments we
confirmed that transfection of a STAT3 specific siRNA led to the
near complete ablation of total STAT3 protein, whereas a control
siRNA had no effect on STAT3 protein levels (Figure 4A). We
found that CagA-related cell polarity defect (hummingbird
phenotype) and the associated SHP2/ERK signalling response
were unperturbed by STAT3 knockdown (Figure 4A–B). That is,
disruption of cell polarity by CagA does not require STAT3. We
next assessed the transcriptional effects of CagA in the context of
STAT3 protein knockdown. CagA-dependent induction of
REG3c and IL-8 was significantly attenuated in STAT3 deficient,
WT-CagA expressing cells (Figure 4C) though, intriguingly, CagA-
dependent IL-11 induction was unaffected by the loss of STAT3
(Figure 4C). The latter result suggests that increased IL-11
transcription (and secretion) is a primary function of CagA with
STAT3 activation and REG3c induction occurring secondarily.
With this in mind we next employed monoclonal antibodies to
selectively block IL-11 ligand/receptor engagement. Consistent
with STAT3 protein knockdown studies, IL-11 neutralising
antibodies attenuated CagA-dependent induction of REG3c
mRNA (Figure 4D). However we found no significant effect of
IL-11 blockade on CagA-dependent IL-8 expression (Figure 4D)
or deregulation of cell polarity (data not shown) though clear
evidence of positive feedback on IL-11 transcription was detected
(Figure 4D). Collectively these data argue that both STAT3 and
IL-11 are key components of the (CagA-dependent) gastric
REG3c response, but are dispensable for CagA mediated
deregulation of cell polarity.
CagA-dependent MAP-kinase pathway activation
negatively regulates STAT3 and mediators of mucosal
innate immunity
To comprehensively differentiate between induction of REG3c
by either JAK/STAT3 or SHP2/ERK signalling we next assessed
the impact of the specific ERK antagonist, PD98059, in WT-
CagA expressing MKN28 cells. Treatment with 50 mM PD98059
(empirically determined in dose response experiments as the
minimum concentration required for effective ERK inhibition;
Figure 2. CagA tyrosine phosphorylation triggers REG3c expression and activates STAT3 signalling. (A) CagA immunoblot (IB) analysis
of WT-CagA and mutant PR-CagA protein expressing MKN28 cells and matched non-induced control cells. (B) Representative photographs of live WT-
CagA and PR-CagA expressing MKN28 cells and matched non-induced control cells. Red scale bars indicate the length (along the longest axis) of
representative cells in each image. Black scale bar in the lower right hand panel shows 100 mm. (C) QRT-PCR analyses of REG3c and IL-8 mRNA in WT-
CagA and PR-CagA expressing MKN28 cells. Histograms show mean mRNA fold change of CagA induced cells compared to non-induced controls. (D)
Immunoblot (IB) analysis of phosphorylated (P)-STAT3 and P-ERK in WT-CagA, PR-CagA induced, or empty vector MKN28 cells compared to non-
induced controls. Histograms show mean fold-change in optical density (OD) of phosphorylated protein bands normalized to total protein bands.
Protein bands from one randomly selected replicate experiment are shown (from a total of n=6 replicates/group). In all cases, protein molecular
weights are indicated (kDa). Error bars show 6 standard error of the mean (SEM). Where present, asterisks indicate statistical significance (P,0.05).
doi:10.1371/journal.pone.0030786.g002
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(Figure 5A), and, as expected on the premise of several published
studies [4,10], completely rescued the cell polarity defect
(Figure 5B). Strikingly, PD98059 treatment significantly aug-
mented CagA-dependent STAT3 signalling, suggesting the
existence of negative regulation by P-ERK (Figure 5A). We
investigated whether altered SHP2 signalling could account for the
apparent release of STAT3 from negative regulation by P-ERK,
but found no significant effect of PD98059 treatment on P-SHP2
levels (data not shown). These results indicate that CagA-
dependent ERK activation might act to restrain parallel signal
transduction via STAT3.
Paradoxically, despite augmented STAT3 signalling, CagA-
dependent induction of REG3c mRNA was not significantly
increased (though a trend to increase was seen) with PD98059
treatment (Figure 5C) suggesting that, in these MKN28 cell lines,
maximum transcriptional output had been reached by CagA
expression alone. Though difficult to dissect from reciprocal effects
on STAT3, these inhibition studies support the view that REG3c
induction does not require positive stimulation by CagA-mediated
SHP2/ERK signal transduction, and is most likely subject to
exclusive regulation by IL-11/gp130/STAT3 signalling. In accor-
dancewiththeprofileofSTAT3activation,transcriptsencodingthe
mucosal immune regulators, IL-6, IL-8 and IRF1, were significantly
upregulated following blockade of CagA-dependent ERK signalling
(Figure 5D). These results suggest that CagA induces these genes
independently of SHP2/ERK signalling (possibly via, or down-
stream of STAT3 activation), and/or that ERK-dependent
Figure 3. IL-11, not IL-6, induces STAT3 signalling and REG3c expression in gastric epithelial cells. (A) CagA induction assay.
Quantitative (Q)RT-PCR analysis of IL-11 and IL-6 in WT-CagA and PR-CagA expressing MKN28 cells. Histograms show mean mRNA fold change of
CagA induced cells compared to non-induced controls. Error bars show the standard error of the mean (SEM). Where present, asterisks indicate
statistical significance (P,0.05). (B) Immunoblot (IB) analysis of STAT3 and ERK activation levels (P-STAT3 and P-ERK) in unmodified (non-stably
transfected) MKN28 cells exposed to 100 ng/mL recombinant human (rh) IL-11 or rhIL-6. Mock treated (control) cells received 0.22% saline carrier. (C)
Quantitative immunoblot (IB) analysis of STAT3 activation in MKN28 cells exposed to 100 ng/mL IL-11 and mock-treated control cells. Histograms
show mean OD values of P-STAT3 bands normalized to total STAT3 bands. Representative immunoblot images are shown (total of n=6 replicate
cultures/group). Protein molecular weights are indicated (kDa). (D) QRT-PCR analysis of REG3c mRNA levels in the MKN28 cells treated with either
100 ng/mL IL-11 (same cell lysates analysed for STAT3 activation in ‘C’) or 10 ng/mL IL-6 (n=6 replicate cultures/group). Histogram shows the mean
mRNA fold-change of rhIL-11/rhIL-6 treated cells compared to mock-treated (saline carrier) controls. Error bars (6SEM). Where present, asterisks
indicate statistical significance (P,0.05).
doi:10.1371/journal.pone.0030786.g003
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immune responses to H. pylori infection (Figure 5D).
Besides deregulating epithelial cell polarity and triggering innate
immunity, CagA has been widely described to alter cell growth
kinetics. Whether the cellular growth response to CagA is
inhibitory or stimulatory is determined by the polarity status of
the recipient epithelial cell [11]. CagA-dependent induction of
transcripts encoding key cell cycle regulators including c-MYC,
Cyclin-D1, CyclinE1 and P21 was partially attenuated following
ERK blockade (Figure S4). This is intriguing since CagA likely
blocks cell cycle progression (Figure S5) by generating a
dominant anti-proliferative response involving the canonical
tumour suppressor genes, P21 [11,25] and Retinoblastoma (pRB1)
(Figure S6). These data therefore implicate positive regulation of
P21 (and other cell cycle regulators) by CagA dependent ERK
signalling. Taken together our findings also show that REG3c
induction occurs independently of cell cycle activity suggesting that
it is separable from the growth effects of CagA. In summary, it
seems likely that target genes acting downstream of CagA, which
mediate either mucosal innate immunity or growth control are
respectively partitioned according to specific regulation by either
JAK/STAT3 or SHP-2/ERK signal transduction.
Discussion
Here we have identified the bactericidal C-type lectin, REG3c,
as a transcriptional target of the principal H. pylori cytotoxin, CagA
in the human stomach. In addition we show that CagA-dependent
regulation of REG3c requires signalling by the IL-6 family
cytokine, IL-11, very likely via the intracellular STAT3 pathway.
This REGc transcriptional response occurs independently of both
CagA-dependent deregulation of epithelial cell polarity or
signalling via the gp130/SHP2/ERK (MAP-kinase) pathway.
On this line, though clearly transducing several immune-related
effects of translocated CagA, STAT3 is entirely dispensable for the
development of the characteristic CagA-mediated cell polarity
defect, the ‘hummingbird phenotype’. This is perhaps unsurprising
since CagA-dependent deregulation of cell polarity has been
unambiguously attributed to downstream effects on Ras-indepen-
dent, SHP-2 and MAP-kinase signalling [4,10]. Nonetheless, we
conclude that CagA-mediated gastric REG3c expression is
activated predominantly by IL-11 and STAT3 signalling. Our
conclusions are broadly corroborated by other studies showing IL-
11 dependent activation of Reg3b/Reg3c in the mouse distal
stomach as well as overexpression of human REG3 orthologues in
Figure 4. STAT3 RNAi mediated knockdown and IL-11 signalling blockade in CagA expressing MKN28 cells. (A–C) RNA-interference
(RNAi) mediated STAT3 protein knockdown. (A) Immunoblots (IB) of total STAT3 and P-ERK in WT-CagA expressing MKN28 cells following transfection
with STAT3-specific small interfering (si)RNA or control siRNA. Histograms show mean OD values of total STAT3 or P-ERK bands respectively
normalized to GAPDH or total ERK bands. Representative immunoblot images are shown (total of n=6 replicate cultures/treatment group). Protein
molecular weights are indicated (kDa). (B) Morphometric analysis of cell length of the same cultures described in ‘A’. Histograms show mean cell
length (mm) of WT-CagA expression induced MKN28 cells and non-induced controls following transfection with STAT3-specific siRNA or control siRNA.
One randomly selected cell image from each treatment group is shown (total of n=6 replicate cultures/group). Red scale bars illustrate length (along
the longest axis) of representative cells from each treatment group. Black scale bar in the lower right hand panel shows 100 mm. (C) QRT-PCR analysis
of REG3c, IL-11 and IL-8 mRNA expression. Histograms show mean mRNA fold change relative to non-CagA induced, control siRNA transfected cells.
(D) IL-11 immuno-neutralisation: QRT-PCR analysis of REG3c, IL-11 and IL-8 mRNA in WT-CagA expressing MKN28 cells following treatment with anti-
human IL-11 specific neutralising antibody or anti-mouse IgG control antibody. Error bars (6SEM). Where present, asterisks indicate statistical
significance (P,0.05).
doi:10.1371/journal.pone.0030786.g004
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activation in gastric precancerous lesions [15].
Phosphorylation status is a key determinant of CagA-mediated
signalling and transcriptional outcomes, with CagA reported to
function predominantly, though not exclusively, in the EPIYA
tyrosine phosphorylated mode [4,6,7,8,9,10]. Accordingly we
found that tyrosine phosphorylated CagA, not unphosphorylated
CagA triggered IL-11 expression, STAT3 activation and REG3c
mRNA induction. In apparent contradiction to our observations, a
recent study reported IL-6Ra dependent activation of STAT3
signalling by CagA, which was also independent of CagA EPIYA
motif tyrosine phosphorylation status [23]. The discrepancy
between our findings and the work of Bronte-Tinkew et al.,i n
terms of both CagA phosphorylation status and ligand/receptor
dependent STAT3 activation mode, is likely due to contrasting
differentiated cell types used in the two respective studies. To
mimic as closely as possible, the obligate ecological niche of H.
pylori, we utilized gastric epithelial cell lines, whilst Bronte-Tinkew
et al. instead used non-gastric, laryngeal carcinoma derived HEp-2
cells. The context of tissue-specificity is a probable extenuating
factor in these opposing experimental endpoints. Indeed it is well
known that stark mechanistic differences in ligand/receptor
mediated STAT3 activation exist between different tissue lineages
[36]. From this perspective, it must be acknowledged that our
investigation in gastric epithelial cells more accurately recapitu-
lates the tissue-specific STAT3 responses typically encountered by
H. pylori in vivo than other studies performed in non-gastric cells.
In this study we observed negative regulation of STAT3 by
CagA-dependent signalling through the SHP2-ERK pathway.
This finding argues that, in addition to effects on epithelial barrier
integrity, CagA-dependent MAP-kinase signalling might facilitate
H. pylori colonisation by restraining pro-inflammatory STAT3
activation and the influence of downstream effector genes. This
supposition is well supported by our observation that CagA-
dependent upregulation of pro-inflammatory IL-8, IL-6 and IRF1
transcripts was enhanced in concert with augmented STAT3
signalling after ERK signalling blockade. IL-8 has been well
described to promote activation and mucosal infiltration of
neutrophils in response to infection with (CagA-positive) H. pylori
[32,33,37]. IL-6 has wide-ranging stimulatory effects on both
adaptive and innate immunity and is also a likely participant in the
mucosal response to H. pylori infection [38,39]. Similarly, IRF1 has
been described as a H. pylori and CagA responsive gene and may
be required for full transcriptional activation of IL-8 [40]. In our
study CagA-dependent IL-8 mRNA induction was partially
dependent on STAT3 (IL-8 expression was significantly attenuated
in the presence of STAT3 siRNA). Regulation of IL-8 transcrip-
tion by STAT3 has been described in other tissue lineages [41,42]
Figure 5. Inhibition of CagA-dependent MAP-kinase pathway activation. (A) Immunoblot (IB) analysis of P-ERK and P-STAT3 in WT-CagA
inducible MKN28 cells treated with 50 mM PD98059 for 72 hours. Histograms show mean OD values of total STAT3 or P-ERK bands respectively
normalized to GAPDH or total ERK protein bands. Protein bands from one randomly selected replicate experiment are shown (from a total of n=6
replicates/group used to generate the histogram data). (B) Morphometric analysis of cell length. Histograms show mean cell length (mm) of WT-CagA
induced MKN28 cells and matched non-induced controls treated with 50 mM PD98059. One randomly selected cell image from each treatment group
is shown (n=6/group). Red scale bars show length (along the longest axis) of representative cells from each treatment group. Black scale bar in the
lower right hand panel shows 100 mm. (C–D) QRT-PCR analysis of cultures described in ‘A’. (C) REG3c and IL-11 mRNA; (D) IL-8, IL-6 and IRF1 mRNA.
Histograms show mean mRNA fold changes relative to non-CagA induced, mock treated (DMSO) cells. Error bars (6SEM). Where present, asterisks
indicate statistical significance (P,0.05).
doi:10.1371/journal.pone.0030786.g005
CagA Triggers REG3c via STAT3
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e30786in addition to our observations here in gastric epithelial cells.
Besides mediating CagA-dependent REG3c induction, STAT3
might also orchestrate broader mucosal immune responses
downstream of translocated CagA, the magnitude of which are
determined by the strength of counteractive CagA-dependent
SHP2-(Ras)-ERK signals.
REG3c is a specialized C-type lectin, having direct bactericidal
activity in the gastrointestinal tract based on peptidoglycan
recognition [27,28,29]. These studies have established a revelatory
paradigm for gastrointestinal biology by elucidating REG3c as a
key homeostatic regulator of intestinal symbiotic host-microbe
relationships. Our findings suggest an analogous, but previously
undescribed role for REG3c in the stomach, thereby alluding to
the existence of lectin-mediated innate immunity which prospec-
tively modifies the gastric microbiome. Defining the microbial
targets of REG3c in the gastric mucosa will be critical to
understanding fully its relationship with H. pylori and these must
now be elucidated by further studies. This is a pertinent avenue for
future research since REG3c is only directly bactericidal against
Gram-positive bacteria [27,28,29] and it is unclear how this
molecule might interact with, or influence H. pylori, a Gram-
negative species. We favour a model in which CagA-dependent
induction of REG3c presents a competitive advantage to H. pylori
at the expense of other gastric microflora (specifically Gram-
positive bacteria) which are directly sensitive to the bactericidal
properties of REG3c. Indeed a recent study, showing significantly
reduced abundance of Gram-positive Actinobacteria and Firmicutes
species in the H. pylori-infected human gastric mucosa [43],
provides empirical support for our argument.
The existence of host mechanisms that might indirectly preserve
H. pylori colonisation necessitates a re-evaluation of the host-
pathogen relationship. While undoubtedly oncogenic, the most
severe outcome of H. pylori pathogenicity, gastric adenocarcinoma,
is manifested in a very small minority of infected individuals (,3/
10,000 individuals/year or 2.1% for lifetime infection) [44]. On
the other hand, the majority of chronically infected individuals
prevail with only superficial gastritis or limited disease progression
and do not develop cancer. Intriguingly, a recent study in a mouse
infection model suggests that, in some individuals, the early
development of tolerance to H. pylori may protect against infection-
related precancerous disease later in life [45]. Within this
framework there is growing debate centred on the notion that
H. pylori infection is not universally deleterious, and may, in fact be
advantageous at least in some instances [46,47,48,49]. Particularly
resonant in this regard are recent studies reporting that H. pylori
infection is protective against gastroesophageal reflux disease
(GERD) and paediatric asthma [48,49,50,51]. This emerging
evidence has engendered a shift in contemporary thinking towards
the concept of H. pylori as a symbiotic colonist, thus moving away
from the exclusively pathogenic role of conventional understand-
ing. Speculatively, this argues for a cost-benefit scenario whereby
the few infected individuals who succumb to intestinal-type gastric
adenocarcinoma essentially ‘pay the price’ on behalf of the
overwhelming majority that instead benefit from putative
‘immunological balancing’ effects of H. pylori infection [48]. As
postulated by others [52], the reciprocity of the host-microbe
relationship might operate by permitting a mild but tolerable
degree of cell lysis arising from low level mucosal inflammation.
Conceivably this process would generate nutrient release which, in
turn would favour ongoing H. pylori colonisation.
In summary, most of what is known about CagA pertains to a
much vaunted role as an early determinant of gastric cancer. By
contrast, considerably less attention has been paid to possible roles
of CagA in the vast majority of chronically infected individuals not
showing oncogenic progression [46]. We have provided novel
evidence that Gram-negative H. pylori, acting via the CagA
cytotoxin, directs expression of the Gram-positive specific
bactericidal lectin, REG3c, in gastric epithelial cells and does so
by activating the IL-11/gp130/STAT3 pathway. While the
functional basis of this response is not entirely clear, we suggest
that CagA-directed REG3c expression may allow H. pylori to
manipulate host immunity to gain survival advantage, by reducing
the fitness of co-habiting Gram-positive bacteria with which it
competes for resources in the gastric mucosal niche.
Materials and Methods
Ethics statement
Human gastric mucosal biopsies were collected by routine
endoscopy under existing human ethics approval from the Royal
Melbourne Hospital Human Research Ethics Committee (ap-
proval number RMH HREC 2004.176). We have recruited
patients to obtain gastric biopsies with pathologist determined
Helicobacter pylori infection and CagA cytotoxin status as well as
non-infected disease-free controls. Written informed consent was
obtained for all participants involved in the study.
Tissue sources
Gastric epithelial biopsies (distal stomach) were obtained from
98 patients of mixed ethnicity undergoing routine gastroscopy at
the Western Hospital, Melbourne, Australia, in accordance with
Ethics Committee approval. Written informed consent was
obtained for all participants involved in the study (see Ethics
statement). Helicobacter pylori infection and CagA cytotoxin status
was determined as described [21].
Gene expression
Total RNA was isolated from tissue and cell lines using Trizol
(Invitrogen) and contaminant genomic DNA removed with DNA-
free reagents (Ambion). Primer sequences were designed using
primer3 (http://frodo.wi.mit.edu/primer3/) and are listed in the
supplemental methods. For quantitative reverse transcription and
polymerase chain reaction (QRT-PCR), oligo-dT primed cDNA
was synthesised from 1 mg total RNA using Murine Moloney
Leukaemia Virus (MMLV) reverse transcriptase (Promega).
QRTPCR was performed on an ABI PrismH 7500 Real Time
PCR System using SYBR green master mix (Applied Biosystems)
according to the manufacturer’s protocols. Relative gene expres-
sion values were obtained by normalization to the reference gene
GAPDH using the 22
DDCt method, where 22DDCt=DCt
sample2DCt calibrator (Applied Biosystems) as described [53].
Mammalian cell culture, transfection and RNA
interference
Human gastric epithelial Tet-OFF MKN28 cell lines with stably
integrated doxycycline (DOX) repressible WT-CagA (WT-A10)
and PR-CagA (PR-C2) transgenes, and parental control cells
(MKNII) were cultured and manipulated as described [25].
Unmodified (non-stably transfected) AGS and MKN28 human
gastric cell lines were maintained in RPMI 1640 medium
supplemented with 10% fetal bovine serum (FBS), 50 IU/mL
penicillin, 50 mg/mL streptomycin (Invitrogen). For transient
overexpression of WT-CagA or PR-CagA proteins, unmodified
AGS and MKN28 cells were transfected with 2 mg supercoiled
plasmid DNA using FuGENE HD (Roche) according to
manufacturer’s protocols. After 48 hours cells were washed in
ice cold PBS and cell lysates obtained using Trizol (Invitrogen).
For STAT3 RNA interference (RNAi) knockdown, CagA-
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trypsinized and washed three times in prewarmed 2% FBS in PBS,
followed by three washes in prewarmed Opti-MEM (Invitrogen).
Washed cells (2610
6 cells/mL) were electroporated with 4 mg
stealth STAT3 siRNA (#46–1468; Invitrogen) or control siRNA.
Electroporated cells were plated in 25 cm
2 flasks and cultured for
72 hours, after which cell lysates were obtained and STAT3
protein knockdown verified by immunoblotting.
Cytokine stimulation and signal transduction inhibition
assays
The source of recombinant human (rh)IL-11 was described
previously [21]. Prior to cytokine stimulation, MKN28 cells were
seeded in 6-well plates and serum starved by incubation in RPMI
1640 medium supplemented 0.5% FBS for 16 hours. Cell cultures
were then incubated with either 100 ng/mL rhIL-11 [21] or
10 ng/mL rhIL-6 (Sigma Aldrich) for 1 hour. To selectively block
IL-11 signalling, WT-CagA inducible MKN28 cells were seeded
in 25 cm
2 flasks (5610
5 cells/flask) and treated with either 10 ug/
mL anti-human IL-11 mouse monoclonal neutralising antibody
(#MAB218; R&D Systems) or 10 ug/mL control anti-mouse IgG
for 72 hours. For inhibition of ERK1/2 MAP-kinase signalling,
cells were treated with the MEK antagonist, PD98059 [54]
(50 mM) or mock treated with DMSO carrier for 72 hours. Signal
transduction outcomes of cytokine stimulation, antibody neutral-
isation or pharmacologic inhibition were determined by immu-
noblotting as described below.
Immunoblotting
Immunoblotting was performed as we described previously
[55]. The sources of primary antibodies are as follows. Rabbit
polyclonals: anti-CagA antigen #HPP-5003-9, diluted 1:1000
(Austral Biologicals); anti-human STAT3 #9132, diluted 1:1000;
anti-human phosphorylated (tyrosine 705) STAT3 #9135, diluted
1:500; anti-human ERK #9102, diluted 1:1000; anti-human
phosphorylated (threonine 202, tyrosine 204) ERK #9101, diluted
1:1000; anti-human SHP2 #3752, diluted 1:1000; anti-human
phosphorylated (tyrosine 542) SHP2 #3751S, diluted 1;500;
phosphorylated (serine 780) retinoblastoma protein 1 (RB1)
#9307, diluted 1:500; anti-human b-actin #4970, diluted
1:3000 (all Cell Signaling Technology); anti-GAPDH #ab9485,
diluted 1:3000 (Abcam). Mouse monoclonals: anti-human RB1
#ab24, diluted 1:1000 (Abcam). Proteins were analysed by
quantitative densitometry using Quantity One software
(BIORAD), where the optical density (OD) of phosphorylated
protein bands was normalized against that of respective total
protein bands, GAPDH or b-actin. Unless stated otherwise, results
were expressed as mean normalized OD of n=6 replicate
cultures/treatment group.
Quantitative live cell morphometry
Images of live cultured cells were captured on an inverted
microscope using a digital camera. A total of six replicate cultures
were analysed for each treatment group. For each replicate/
culture flask, three random fields were photographed and for each
field, cell length (taken as the distance in mm along the longest cell
axis) was determined for three random cells using ImageJ software
(http://rsbweb.nih.gov/ij/download.html).
Statistical analysis
All data expressed as mean 6 standard error of the mean
(SEM). Comparisons between data groups were made using
SigmaStat software (SPSS). T-tests were used for parametric
comparisons and where necessary, Mann-Whitney Rank Sum tests
were used for nonparametric comparisons. Probability (P) values of
,0.05 were considered statistically significant.
Supporting Information
Figure S1 CagA inducible expression in doxycycline
repressible Tet-OFF MKN28 cells. The Tet-OFF system was
used to inducibly express WT-CagA and phosphorylation resistant
(PR) CagA mutant cDNAs in human gastric epithelial MKN28
cells. In the Tet-Off system, transcription of the gene of interest is
repressed in the presence of the tetracycline analogue, doxycycline
(DOX) and maximally expressed in the absence of DOX. In the
panel above, stably transfected, WT-CagA inducible Tet-OFF
MKN28 cells were treated with a range of DOX concentrations
(0–2000 ng/mL) for 24 hours, total protein lysates obtained and
immunoblotted (IB) with a specific antibody to CagA. The
immunoblot results show that WT-CagA protein expression is
induced with decreasing DOX concentration. Similar results were
obtained in PR-CagA inducible Tet-OFF MKN28 cells (data not
shown). The b-actin immunoblot verifies equivalent total protein
loading in all lanes. All experiments described in this study
compare cellular responses between non-induced CagA (2000 ng/
mL DOX) and fully induced CagA (no DOX treatment).
(TIF)
Figure S2 STAT3 activation following transient overex-
pression of CagA protein. Unmodified AGS and MKN28 cells
were transiently transfected with constructs carrying either WT-
CagA, or PR-CagA cDNAs driven by the constitutive SR-alpha
(SV40/R-U5 T-cell leukaemia virus) promoter fragment, empty
vector or mock transfected. Total cellular protein lysates were
collected at 48 hours post transfection and immunoblotted for
phosphorylated (P)-STAT3, total STAT3 and CagA proteins.
Histograms show mean optical densities of P-STAT3 protein
bands normalized to total STAT3 protein bands. Protein bands
from one randomly selected replicate experiment are shown (from
a total of n=3 replicates/group used to generate the histogram
data). Protein molecular weights (kDa) are indicated to the right of
the immunoblot images. Error bars (6SEM). Where present,
asterisks indicate statistical significance (P,0.05).
(TIF)
Figure S3 Optimisation of PD98059-mediated ERK
inhibition. Tet-OFF MKN28 WT-CagA inducible cells were
treated with different concentrations (0–100 mM) of the MEK
(proximal activator of ERK) inhibitor PD98059 for 24 hours.
Control cells received an appropriate volume of DMSO carrier.
To determine ERK activation levels in response to PD98059
treatment, cell protein lysates were obtained and immunoblotted
(IB) for total and phosphorylated (P) forms of ERK. Molecular
weight of protein bands is indicated (kDa). Treatment with 50 mM
PD98059 was the minimum concentration required for sustained
ERK inhibition.
(TIF)
Figure S4 CagA-dependent induction of cell cycle regu-
lator genes following ERK signalling blockade. Quantita-
tive (Q) RT-PCR analysis of P21, cMYC, CYCLIN-D1 and
CYCLIN-E1 mRNA expression in CagA expressing (+) and non-
induced control cells (2) treated with 50 mM PD98059 or mock
treated (DMSO). Histograms show the mean mRNA fold-change
compared to non-induced, mock treated cells. Error bars (6SEM).
Where present, asterisks indicate statistical significance (P,0.05).
(TIF)
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growth inhibition of gastric epithelial cells. CagA
induction assay showing CFSE proliferation profiles generated
by flow cytometric analysis of WT-CagA and PR-CagA expressing
cells together with empty vector control cells. The uppermost
panels plot initial numbers of CFSE labelled cells at 0 hours
(Parent generation), whilst the middle and lower panels plot cell
numbers against CFSE intensity signals for non-induced controls
(2) and CagA expression induced (+) cells respectively after
72 hours in culture. Successive cell generations from 1(parent) to 7
are indicated by the colour key. White and black arrowheads in
the WT-CagA panels respectively illustrate the differential in
CFSE fluorescence intensity between induced cells which have
arrested in generation 5 and non-induced cells which have
continued to divide.
(TIF)
Figure S6 CagA tyrosine phosphorylation deregulates
the cell cycle modulators RB1 and P21. (A) CagA induction
assay showing immunoblot (IB) analysis of Retinoblastoma protein
(RB)1 activity. Histograms show mean fold-change in optical
density (OD) of phosphorylated (P)-RB1 protein bands normalized
to total RB1 protein in WT-CagA and PR-CagA expressing
MKN28 cells compared to non-induced control cells. Blot images
from one experiment are shown (from a total of n=6 replicate
cultures/group used to generate the histogram data). (B) QRT-
PCR analysis of P21 mRNA expression. Histograms show the
mean mRNA fold-change in WT-CagA and PR-CagA expressing
cells compared to the respective non-induced controls. Error bars
(+/2SEM). Where present, asterisks indicate statistical signifi-
cance (P,0.05).
(TIF)
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